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Induced pluripotencyAbstract Reprogramming of adult somatic cells into induced pluripotent stem cells (iPSCs) has
attracted considerable attention in both the scientific and public communities. This is due to the
importance of iPSCs in drug screening, disease modeling, cell transplantation therapies and regen-
erative medicine. A lot of efforts have been devoted to the generation of iPSCs with fewer repro-
gramming factors and with higher efficiencies. It has been shown that removal of reprogramming
barriers increases the efficiency of iPSC generation from differentiated cells up to 90%. Interest-
ingly, having relatively fast cell cycle kinetics, plasticity and endogenous expression of particular
pluripotency regulators make adult stem/progenitor cells potentially elite cells poised to become
iPSCs. Moreover, it has been demonstrated that adult stem/progenitor cells are more amenable
to pluripotent reprogramming than mature cells. Accordingly, it is hypothesized that certain adult
stem cells could be reprogrammed into iPSCs without overexpression of exogenous pluripotency
transcription factors by only combinatorial modulation of barriers and enhancers and relying on
the endogenous expression of key reprogramming factors (e.g. Oct4, Sox2, etc.).
 2015 Tehran University of Medical Sciences. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Somatic cells from different species (e.g. mouse [1–4], rat [5,6],
monkey [7] and human [8–11]) have been reprogrammed into
iPSCs by overexpression of pluripotency transcription factors
most commonly Oct4, Sox2, c-Myc and Klf4 (OSKM) inmouse, and Oct4, Sox2, Nanog and Lin28 in human cells.
Human iPSCs are an important alternative cell source for
patient-specific cell-based therapies due to their ability
for unlimited self-renewal and pluripotent differentiation.
Interestingly, derivatives of pluripotent stem cells have been
introduced to the clinic, representing the promise of a new009723;
Fig. 1 A schematic representation of the proposed theory. The removal of reprogramming barriers could enable adult stem/progenitor
cells to be reprogrammed into iPSCs without ectopic expression of exogenous factors relying on the endogenous expression of
pluripotency master regulators and appropriate extracellular cues.
100 B. Ebrahimiera for regenerative medicine [12–15]. However, the genetic
manipulation of reprogrammed cells limits their applications
in regenerative medicine. This issue highlights the importance
of integration-free reprogramming methods for the generation
of iPSCs. Moreover, pluripotent reprogramming is an ineffi-
cient process due to various defined and undefined barriers
[16]. Indeed, the main drawback of reprogramming is its low
efficiency [17]. It has been assumed that the somatic programs
or somatic gene regulatory networks (GRNs) protect the cells
from aberrant transformations and provide barriers to an effi-
cient reprogramming [18–20]. Pluripotent reprogramming
should overcome the epigenetic state of a differentiated
somatic cell to make it compatible with the pluripotent state.
Thus, an important factor affecting the efficiency of repro-
gramming is the differentiation state of the starting (donor)
cells, which acts as a barrier to efficient epigenetic remodeling
of the genome [21]. Different barriers of reprogramming (p53,
p21, p57, p16Ink4a/p19Arf, Mbd3, etc.) have comprehensively
reviewed elsewhere [16]. It has been demonstrated that removal
of the main barriers of somatic cell reprogramming or
combinatorial modulation of barriers and enhancers
dramatically improves the efficiency of the process to nearly
100% [22,23]. However, somatic programs and epigenetic
barriers of reprogramming seem to be more strict in
differentiated cells than stem/progenitor cells, which are in a
plastic state [21]. Adult stem cells are undifferentiated cells
with plasticity and self-renewal capacity [24,25]. Interestingly,
adult stem and progenitor cells have certain similarities with
pluripotent stem cells, such as the ability to differentiate into
distinct cell types and the expression of specific pluripotency
regulators [26,27]. Furthermore, different studies have con-
firmed that adult stem/progenitor cells are more amenable to
reprogramming than mature cells and can be efficiently
reprogrammed into iPSCs [21,28–32]. This study considers
the possibility of reprogramming of adult stem cells into iPSCs
without ectopic expression of pluripotency transcription
factors by only depletion of barriers and activation of
enhancers (Fig. 1).
The hypotheses/ideas
Considerable efforts have been devoted to developing
various methods for improving the reprogramming efficiency
[16]. Surprisingly, it has been indicated that mouse iPSCs
can be produced by a chemical cocktail and withoutreprogramming factors, but with delayed kinetics and low effi-
ciency [33]. This finding shows that induction of pluripotency
in mouse cells can be accomplished in the absence of
reprogramming transcription factors; however, overexpression
of reprogramming factor(s) still is essential for efficient induc-
tion of reprogramming [16]. Adult stem cells and progenitors
are in a plastic state and express certain pluripotency
regulators [25,34–36]. Moreover, findings have demonstrated
that these cells are more amenable to reprogramming than
differentiated cells [21]. It could be suggested that differences
between pluripotency and multipotency arise from distinct
genetic and epigenetic barriers, which lock multipotent stem
cells in a restricted state of potency and prevent them from
aberrant transformations to pluripotency and malignancies.
In addition, stem and progenitor cells do not express
lineage-specific genes, which can hamper reprogramming and
in turn express certain embryonic stem (ES) cell markers
[25,34–36], which could allow their efficient reprogramming.
Therefore, the use of stem/progenitor cells that endogenously
express appropriate levels of pluripotency factors as
starting cells can reduce the number of reprogramming factors
for iPSC production [29,37]. Consequently, it could be
hypothesized that adult stem/progenitor cells can be simply
reprogrammed into iPSCs without overexpression of repro-
gramming factors by only depletion of reprogramming barriers
and application or activation of enhancers (Fig. 1).
Evaluation of the hypotheses/ideas
A large number of reprogramming barriers have
been identified hitherto, including p53-p21 pathway,
Wnt/b-catenin, TGF-b and Hippo signaling pathways,
histone H3 Lysine 9 (H3K9) methylation, histone H3
Lysine 79 (H3K79) methylation, H3K36me2/3 marks,
histone deacetylation and MBD3/NuRD complex [16].
Depletion or inhibition of these barriers has been success-
ful to enhance reprogramming efficiency of somatic cells.
Furthermore, activation of specific genes and pathways
can accelerate the process [16].
Thus, for evaluating the applicability of the induction of
pluripotency in adult stem/progenitor cells without overex-
pression of exogenous reprogramming factors, it is suggested
that chemical or biological molecules (e.g. siRNAs or small
molecules), which can inhibit barriers or activate enhancers
either separately or together, are administered in cultures of
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cells are cultured in pluripotent-supportive reprogramming
media.Discussion
Different methods are developed for enhancing the efficiency
of iPSC production. It has been shown that removal of
reprogramming roadblocks facilitates and accelerates OSKM
reprogramming function [16].
To achieve the minimum number of reprogramming
factors, multiple studies have been done on differentiated cells.
Morrisey and colleagues revealed that expression of the
miR302/367 cluster in combination with Hdac2 suppression
substitutes OSKM and rapidly and efficiently reprograms
mouse and human somatic cells to iPSCs by activating endoge-
nous Oct4 and its targets [38]. Wang et al. demonstrated that
overexpression of high-performance synthetic OCT4-VP16
alone reprograms mouse embryonic fibroblasts (MEFs) into
iPSCs [39]. Therefore, Oct4 activation seems essential for
reprogramming.
Interestingly, pluripotency factor-induced transdifferentia-
tion is a fate conversion approach that uses iPSC transcrip-
tion factor(s) to induce an unstable or plastic cell state in
mature cells [40–48]. The generated plastic cells by this
approach become responsive to environmental cues and can
be transdifferentiated toward various fates [40–48]. In order
to minimize manipulations in this paradigm, it has been
demonstrated that Oct4 alone in combination with short-
term exposure to reprogramming medium is sufficient to
induce a plastic state in human fibroblasts [44–46]. Surpris-
ingly, Salci et al. showed that continued and prolonged
(45–93 days) culture of human OCT4-induced plastic
fibroblasts (plastic hFibOCT4) in a pluripotent-supportive
reprogramming media is sufficient for their pluripotent repro-
gramming [49]. The underlying mechanism of Oct4-induced
plasticity remained to be elucidated, but a possible explana-
tion for this kind of induced plasticity is Oct4-mediated extin-
guishment of native GRNs. Therefore, expression of Oct4
and disruption of the somatic GRNs are critical factors
during successful reprogramming to pluripotency. Various
methods of somatic cell reprogramming have indicated that
the activity of exogenous or endogenous Oct4 is indispensable
during the reprogramming process and there is no substitute
that can replace Oct4’s function in the absence of other
reprogramming factors [49,50].
It has long been known that stem/progenitor cells (e.g. mes-
enchymal stem cells (MSCs)) express certain pluripotency reg-
ulators. For instance, MSCs from human bone marrow
[34,35], adipose tissue, heart, dermis [34] and dental pulp
[25,36] express certain key pluripotency genes (e.g. Oct4,
Nanog, Sox2). Moreover, OCT4 has similar target genes and
regulatory circuitries in human embryonic stem cells (hESCs)
and human bone marrow mesenchymal stem cells (hBMSCs)
[35]. Additionally, there is evidence that shows that tissue
stem/progenitor cells could be initiators or origin of cancer
due to their longevity and self-renewal capacity [51–53]. Fur-
thermore, results from somatic cell nuclear transplantation
have revealed that transferred nucleus of neural stem cells
and keratinocyte stem cells produce cloned embryos more
efficiently than differentiated cells [54,55]. Collectively, thesefindings represent adult stem cells as valuable sources for iPSC
production.
To this end, several groups have endeavored to reprogram
adult stem cells and progenitors with more efficiency or with
fewer factors. For instance, it has been revealed that Oct4
and Sox2 can reprogram cord blood-derived CD133+ stem
cells into iPSCs, whereas they are unable to generate iPSCs
from differentiated keratinocytes and fibroblasts [28]. Further-
more, Kim and colleagues showed that Oct4 alone is sufficient
for the generation of iPSCs from mouse and human neural
stem cells (NSCs), which endogenously express Sox2, c-Myc,
Klf4 and SSEA1 [29,37]. Hochedlinger and colleagues
demonstrated that differentiation stage of starting cells has
an intense impact on the efficiency and kinetics of reprogram-
ming, and that hematopoietic stem and progenitor cells can be
reprogrammed 300 times more efficient than terminally
differentiated cells. They demonstrated that hematopoietic
stem/progenitor cells are more amenable to reprogramming
than differentiated cell types because their epigenetic state is
more permissible to transcription factor-induced remodeling
[21]. Similarly, Park et al. revealed that human endometrial
cells, which endogenously express elevated levels of
pluripotency factors are more amenable to reprogramming
to pluripotency than fibroblasts [56]. Moreover, Vidal et al.
recently showed that specific progenitor cells have simpler
requirements than fibroblasts for highly efficient and syn-
chronous reprogramming [23].
These data are indicative of a ‘‘primed” state in stem/pro-
genitor cells for efficient acquisition of pluripotency in defined
conditions [23]. This property may be due to some intrinsic
features of stem/progenitor cells, including expression of stem-
ness related genes, permissible chromatin state, a decreased
level of barriers (e.g. TGF-b and MAP kinase pathways) and
increased levels of genetic and epigenetic facilitators
(e.g. KDM2B) that favor reprogramming [23]. Possibly, differ-
ences between embryonic and adult stem cells can originate
from specific intrinsic barriers, which in a fine tuning process
regulate gene expression levels desired for the maintenance of
pluripotency or multipotency.
There are data that demonstrate that (1) removal of barri-
ers or activation of enhancers can increase the reprogramming
efficiency of mature cells to 100% [22,23] (well discussed by
Ebrahimi [16]), (2) stem/progenitor cells can be reprogrammed
more efficiently than mature cells [21], (3) stem/progenitor cells
can be reprogrammed with fewer factors [29,37], (4) combina-
torial modulation of barriers and enhancers can improve
reprogramming efficiency of stem/progenitor cells to nearly
100% [23]. According to these findings, it may be possible to
convert stem/progenitor cells, which have a reservoir of repro-
gramming transcription factors, into iPSCs without exogenous
expression of pluripotency factors by only depletion of repro-
gramming barriers and activation of enhancers (Fig. 1).
Although this is an interesting concept, it still needs to be con-
firmed by experimental evidence.
Collectively, depletion of barriers and activation of enhanc-
ing pathways could be a very fast, inexpensive, feasible and
accessible method for reprogramming of adult stem/progenitor
cells into iPSCs. Clinically, this approach could be a safe and
efficient method of iPSC derivation from tissues (e.g. dental
pulp, adipose, bone marrow, etc.) taken from patients and pro-
vides promising hopes for stimulation of tissue-specific progen-
itor cells in situ to proliferate and regenerate injuries or
102 B. Ebrahimideficiencies. Moreover, generation of iPSCs without repro-
gramming factors can accelerate the clinical application of
these cells and reprogramming technology in order to regener-
ative purposes.Overview Box
First question: What do we already know about the
subject?
Low efficiency of pluripotent reprogramming can be
improved by removing reprogramming barriers. The find-
ings demonstrate that adult stem cells are more amenable
to reprogramming than differentiated cells, possibly due
to endogenous expression of certain reprogramming fac-
tors. Suggestively, adult stem cells could be converted into
iPSCs by only depletion of barriers and activation of
enhancers relying on the endogenous expression of speci-
fic pluripotency factors and appropriate extracellular
stimuli.
Second question: What does the proposed theory add to
the current knowledge available, and what benefits does it
have?
Generation of patient specific-iPSCs holds tremendous
promise for the treatment of human disease. If the pro-
posed theory which addressed here is confirmed by future
investigations, safe, integration-free and clinical-grade
iPSCs can be generated more efficiently by a simple
non-integrating technique [57]. Ultimately, this theory
offers a faithful and highly efficient reprogramming
method that could provide powerful tools for research
studies, disease modeling, drug screening and cell trans-
plantation therapies.
Third question: Among numerous available studies, what
special further study is proposed for testing the idea?
It is proposed that adult stem cells derived from vari-
ous tissues (e.g. bone marrow, adipose, dental pulp,
umbilical cord, etc.) are cultured in reprogramming med-
ium containing factors capable of modulation of barriers
(i.e. inhibition) and enhancers (i.e. activation).Conflicts of interest
The author declares that there are no conflicts of interest.Acknowledgement
I would like to thank Mohammad Hossein Soltani, and
Mahdieh Namayandeh from Yazd Cardiovascular Research
Center for their administrative supports.
References
[1] Takahashi K, Yamanaka S. Induction of pluripotent stem cells
from mouse embryonic and adult fibroblast cultures by defined
factors. Cell 2006;126:663–76.
[2] Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed
fibroblasts show global epigenetic remodeling and widespread
tissue contribution. Cell Stem Cell 2007;1:55–70.[3] Okita K, Ichisaka T, Yamanaka S. Generation of germline-
competent induced pluripotent stem cells. Nature 2007;448:
313–7.
[4] Wernig M, Meissner A, Foreman R, et al. In vitro
reprogramming of fibroblasts into a pluripotent ES-cell-like
state. Nature 2007;448:318–24.
[5] Liao J, Cui C, Chen S, et al. Generation of induced pluripotent
stem cell lines from adult rat cells. Cell Stem Cell 2009;4:11–5.
[6] Li W, Wei W, Zhu S, et al. Generation of rat and human
induced pluripotent stem cells by combining genetic
reprogramming and chemical inhibitors. Cell Stem Cell 2009;4:
16–9.
[7] Liu H, Zhu F, Yong J, et al. Generation of induced pluripotent
stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell
2008;3:587–90.
[8] Lowry WE, Richter L, Yachechko R, et al. Generation of
human induced pluripotent stem cells from dermal fibroblasts.
Proc Nat Acad Sci U S A 2008;105:2883–8.
[9] Park IH, Zhao R, West JA, et al. Reprogramming of human
somatic cells to pluripotency with defined factors. Nature 2008;
451:141–6.
[10] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of
pluripotent stem cells from adult human fibroblasts by defined
factors. Cell 2007;131:861–72.
[11] Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent
stem cell lines derived from human somatic cells. Science 2007;
318:1917–20.
[12] Strauss S. Geron trial resumes, but standards for stem cell trials
remain elusive. Nat Biotechnol 2010;28:989–90.
[13] Qiu D, Ye S, Ruiz B, et al. Klf2 and Tfcp2l1, two Wnt/b-
Catenin targets, act synergistically to induce and maintain naive
pluripotency. Stem Cell Rep 2015;5:314–22.
[14] Cyranoski D. Stem cells cruise to clinic. Nature 2013;494:413.
http://dx.doi.org/10.1038/494413a (28 February 2013).
[15] Cyranoski D. Japanese woman is first recipient of next-
generation stem cells, <http://dx.doi.org/10.1038/nature.2014.
15915>; 2014 [accessed September 12].
[16] Ebrahimi B. Reprogramming barriers and enhancers: strategies
to enhance the efficiency and kinetics of induced pluripotency.
Cell Regener 2015. http://dx.doi.org/10.1186/s13619-015-
0024-9.
[17] Hochedlinger K, Plath K. Epigenetic reprogramming and
induced pluripotency. Development 2009;136:509–23.
[18] Cahan P, Li H, Morris Samantha A, et al. CellNet:
network biology applied to stem cell engineering. Cell 2014;
158:903–15.
[19] Morris Samantha A, Cahan P, Li H, et al. Dissecting engineered
cell types and enhancing cell fateconversion via CellNet. Cell
2014;158:889–902.
[20] Tomaru Y, Hasegawa R, Suzuki T, et al. A transient disruption
of fibroblastic transcriptionalregulatory network facilitates
trans-differentiation. Nucleic Acids Res 2014;158:903–15.
[21] Eminli S, Foudi A, Stadtfeld M, et al. Differentiation stage
determines potential of hematopoietic cells for reprogramming
into induced pluripotent stem cells. Nat Genet 2009;41:968–76.
[22] Rais Y, Zviran A, Geula S, et al. Deterministic direct
reprogramming of somatic cells to pluripotency. Nature 2013;
502:65–70.
[23] Vidal SE, Amlani B, Chen T, et al. Combinatorial modulation of
signaling pathways reveals cell-type-specific requirements for
highly efficient and synchronous iPSC reprogramming. Stem
Cell Rep 2014;3:574–84.
[24] Korbling M, Estrov Z, Champlin R. Adult stem cells and tissue
repair. Bone Marrow Transplant 2003;32(Suppl 1):S23–4.
[25] Ebrahimi B, Yaghoobi MM, Kamal-abadi AM, et al. Human
dental pulp stem cells express many pluripotency regulators and
differentiate into neuronal cells. Neural Regen Res 2011;6:
2666–72.
Reprogramming of adult stem/progenitor cells 103[26] Ellis P, Fagan BM, Magness ST, et al. SOX2, a persistent
marker for multipotential neural stem cells derived from
embryonic stem cells, the embryo or the adult. Dev Neurosci
2004;26:148–65.
[27] Galan-Caridad JM, Harel S, Arenzana TL, et al. Zfx controls
the self-renewal of embryonic and hematopoietic stem cells. Cell
2007;129:345–57.
[28] Giorgetti A, Montserrat N, Aasen T, et al. Generation of
induced pluripotent stem cells from human cord blood using
OCT4 and SOX2. Cell Stem Cell 2009;5:353–7.
[29] Kim JB, Sebastiano V, Wu G, et al. Oct4-induced pluripotency
in adult neural stem cells. Cell 2009;136:411–9.
[30] Niibe K, Kawamura Y, Araki D, et al. Purified mesenchymal
stem cells are an efficient source for iPS cell induction. PLoS
One 2011;6:e17610.
[31] Wang J, Gu Q, Hao J, et al. Generation of induced pluripotent
stem cells with high efficiency from human umbilical cord blood
mononuclear cells. Genomics Proteomics Bioinformatics
2013;11:304–11.
[32] Yulin X, Lizhen L, Lifei Z, et al. Efficient generation of induced
pluripotent stem cells from human bone marrow mesenchymal
stem cells. Folia Biol 2012;58:221–30.
[33] Hou P, Li Y, Zhang X, et al. Pluripotent stem cells induced from
mouse somatic cells by small-molecule compounds. Science
2013;341:651–4.
[34] Riekstina U, Cakstina I, Parfejevs V, et al. Embryonic stem cell
marker expression pattern in human mesenchymal stem cells
derived from bone marrow, adipose tissue, heart and dermis.
Stem Cell Rev 2009;5:378–86.
[35] Greco SJ, Liu K, Rameshwar P. Functional similarities among
genes regulated by OCT4 in human mesenchymal and
embryonic stem cells. Stem Cells 2007;25:3143–54.
[36] Al-Habib M, Yu Z, Huang GT. Small molecules affect human
dental pulp stem cell properties via multiple signaling pathways.
Stem Cells Dev 2013;22:2402–13.
[37] Kim JB, Greber B, Arauzo-Bravo MJ, et al. Direct
reprogramming of human neural stem cells by OCT4. Nature
2009;461:643–9.
[38] Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient
miRNA-mediated reprogramming of mouse and human somatic
cells to pluripotency. Cell Stem Cell 2011;8:376–88.
[39] Wang Y, Chen J, Hu JL, et al. Reprogramming of mouse and
human somatic cells by high-performance engineered factors.
EMBO Rep 2011;12:373–8.
[40] Efe JA, Hilcove S, Kim J, et al. Conversion of mouse fibroblasts
into cardiomyocytes using a direct reprogramming strategy. Nat
Cell Biol 2011;13:215–22.
[41] Kim J, Efe JA, Zhu S, et al. Direct reprogramming of mouse
fibroblasts to neural progenitors. Proc Natl Acad Sci U S A
2011;108:7838–43.[42] Wang H, Cao N, Spencer CI, et al. Small molecules enable
cardiac reprogramming of mouse fibroblasts with a single factor,
Oct4. Cell Rep 2014;6:951–60.
[43] Zhu S, Ambasudhan R, Sun W, et al. Small molecules enable
OCT4-mediated direct reprogramming into expandable human
neural stem cells. Cell Res 2014;24:126–9.
[44] Szabo E, Rampalli S, Risueno RM, et al. Direct conversion of
human fibroblasts to multilineage blood progenitors. Nature
2010;468:521–6.
[45] Mitchell R, Szabo E, Shapovalova Z, et al. Molecular evidence
for OCT4-induced plasticity in adult human fibroblasts required
for direct cell fate conversion to lineage specific progenitors.
Stem Cells 2014;32:2178–87.
[46] Mitchell RR, Szabo E, Benoit YD, et al. Activation of neural
cell fate programs toward direct conversion of adult human
fibroblasts into tri-potent neural progenitors using OCT-4. Stem
Cells Dev 2014;23:1937–46.
[47] Bar-Nur O, Verheul C, Sommer AG, et al. Lineage conversion
induced by pluripotency factors involves transient passage
through an iPSC stage. Nat Biotechnol 2015;33:761–8.
[48] Maza I, Caspi I, Zviran A, et al. Transient acquisition of
pluripotency during somatic cell transdifferentiation with iPSC
reprogramming factors. Nat Biotechnol 2015;33:769–74.
[49] Salci KR, Lee JB, Mitchell RR, et al. Acquisition of
pluripotency through continued environmental influence on
OCT4-induced plastic human fibroblasts. Stem Cell Res 2015;
15:221–30.
[50] Sterneckert J, Hoing S, Scholer HR. Concise review: Oct4
and more: the reprogramming expressway. Stem Cells 2012;30:
15–21.
[51] Sell S. On the stem cell origin of cancer. Am J Pathol 2010;176:
2584–94.
[52] Visvader JE. Cells of origin in cancer. Nature 2011;469:314–22.
[53] White AC, Lowry WE. Refining the role for adult stem cells as
cancer cells of origin. Trends Cell Biol 2014.
[54] Blelloch R, Wang Z, Meissner A, et al. Reprogramming
efficiency following somatic cell nuclear transfer is influenced
by the differentiation and methylation state of the donor
nucleus. Stem Cells 2006;24:2007–13.
[55] Li J, Greco V, Guasch G, et al. Mice cloned from skin cells. Proc
Natl Acad Sci U S A 2007;104:2738–43.
[56] Park JH, Daheron L, Kantarci S, et al. Human endometrial cells
express elevated levels of pluripotent factors and are more
amenable to reprogramming into induced pluripotent stem cells.
Endocrinology 2011;152:1080–9.
[57] Lee AS, Tang C, Rao MS, et al. Tumorigenicity as a clinical
hurdle for pluripotent stem cell therapies. Nat Med 2013;19:
998–1004.
